Deferred Tax Assets, Valuation Allowance of 89bio, Inc. from 31 Dec 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
89bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2018 to 31 Dec 2024.
  • 89bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $214,588,000, a 98% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

89bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $214,588,000 +$106,358,000 +98% 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q4 2023 $108,230,000 +$32,248,000 +42% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $75,982,000 +$33,936,000 +81% 31 Dec 2022 10-K 01 Mar 2024 2023 FY
Q4 2021 $42,046,000 +$20,110,000 +92% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q4 2020 $21,936,000 +$11,914,000 +119% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q4 2019 $10,022,000 +$6,520,000 +186% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q4 2018 $3,502,000 31 Dec 2018 10-K 18 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.